vimarsana.com

Latest Breaking News On - Managing director siddharth mittal - Page 1 : vimarsana.com

Latest News | Biocon Inks Licensing, Supply Pact with South Korea s Handok for Chronic Weight Management Product

Get latest articles and stories on Latest News at LatestLY. Biocon Ltd on Friday said it has signed an exclusive licensing and supply agreement with South Korea's Handok for commercialisation of its complex drug product, synthetic Liraglutide, used in the treatment of chronic weight management. Latest News | Biocon Inks Licensing, Supply Pact with South Korea's Handok for Chronic Weight Management Product.

New delhiSouth koreaKyonggi doSouth koreanYoungjin kimSiddharth mittalBiocon ltd onBiocon ltdManaging director siddharth mittalChairman youngjin kim

Biocon Partners with Handok for Chronic Weight Management Drug

Biocon Partners with Handok for Chronic Weight Management Drug
indiainfoline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiainfoline.com Daily Mail and Mail on Sunday newspapers.

Kyonggi doSouth koreaSouth koreanSiddharth mittalYoungjin kimBiocon ltdManaging director siddharth mittalChairman youngjin kim

Biocon s Q3 Net Profit Hits Rs 660 Crore, Revenue at Rs 4,519 Crore

Bengaluru-based pharmaceutical giant, Biocon Ltd, has revealed its fiscal third-quarter financial results.

Kiran mazumdar shawSiddharth mittalBiocon biologicsResearch servicesBiocon ltdChairperson kiran mazumdar shawEmerging marketsManaging director siddharth mittalPharmaceutical giantBiocon ltd

Biocon s net profit doubles to Rs 172 7 crore in Q2 – India Education | Latest Education News | Global Educational News

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year. According to the compa

United statesNew zealandShreehas tambeSiddharth mittalBiocon biologicsJonathan huntManufacturing servicesBiocon ltdBiocon biologics ltdNorth americaEmerging marketsManaging director siddharth mittalNorth americanGeneric formulationsManaging director shreehas tambeManaging director jonathan hunt

Biocon s net profit doubles to Rs 172 7 crore in Q2

Indian pharmaceutical giant Biocon on Friday reported a net profit of Rs 172.7 crore in the September quarter of financial year 2023-24, more than double its profit of Rs 81.8 crore in the same period of the previous year.According to the .

New zealandUnited statesBiocon biologicsJonathan huntShreehas tambeSiddharth mittalBiocon biologics ltdManufacturing servicesBiocon ltdNorth americaEmerging marketsManaging director siddharth mittalNorth americanGeneric formulationsManaging director shreehas tambeManaging director jonathan hunt

vimarsana © 2020. All Rights Reserved.